Annual report
2269.TEDINET S100TZLX
Period2023-04-01 → 2024-03-31
Filed2024-07-04
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100TW0N. Amended by S100TZTL (2024-07-04).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.11T | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥1.06T | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥1.01T | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.19T | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.25T | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥84.3bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥75.4bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥76.0bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥74.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥94.0bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥110.2bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥103.3bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥87.5bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥95.4bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥50.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥69.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥87.5bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥65.7bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥67.3bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥53.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥71.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥1.21T | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥1.14T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.12T | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.07T | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥998.9bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥417.5bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥384.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥787.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥751.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥713.0bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥659.4bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥597.6bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥106.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥63.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥102.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥60.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥39.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥37.1bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥108.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥85.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥127.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥123.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥114.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥24.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥36.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥27.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥93.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥70.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥43.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥54.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥77.0bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥28.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥30.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥181.64 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.39 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥303.62 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥226.26 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.04 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,674.72 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,553.69 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,390.76 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,141.4 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,939.59 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 61.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.2% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.3% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.9% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.0% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.5% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.1% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 17,270 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 17,290 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 17,336 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 17,832 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 17,571 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥30.6bn | 2023-04-01 → 2024-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥28.1bn | 2022-04-01 → 2023-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥34.5bn | 2021-04-01 → 2022-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥25.5bn | 2020-04-01 → 2021-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥23.3bn | 2019-04-01 → 2020-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥24.3bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥23.2bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥24.9bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥23.9bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥31.1bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥22.9bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥21.1bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥35.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥28.9bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥32.9bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥28.3bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥31.7bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥22.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥21.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥364.8bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥369.2bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥391.4bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥386.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥378.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥120.5bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥130.8bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥244.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥238.4bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥246.0bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥266.1bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥262.2bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥33.6bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.9bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥117.79 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.97 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.12 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.03 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.84 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥95 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥170 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥160 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥874.99 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥855.11 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥873.6 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥917.04 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥903.8 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 67.0% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.9% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.6% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 293,459,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 148,369,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 148,369,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 152,683,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 152,683,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 116 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 99 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 85 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 66 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 54 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥544m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥322m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥742m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥742m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥2.7bn |
| Foodreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥46.4bn |
| Foodreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥45.3bn |
| Foodreportable segment | employees | at 2024-03-31 | 10396 pure |
| Foodreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥900.1bn |
| Foodreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥899.4bn |
| Foodreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥721m |
| Foodreportable segment | segment assets | at 2024-03-31 | ¥865.7bn |
| Foodreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥64.3bn |
| Pharmaceuticalsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥15.6bn |
| Pharmaceuticalsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥9.7bn |
| Pharmaceuticalsreportable segment | employees | at 2024-03-31 | 6753 pure |
| Pharmaceuticalsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥206.1bn |
| Pharmaceuticalsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥206.1bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥20m |
| Pharmaceuticalsreportable segment | segment assets | at 2024-03-31 | ¥337.6bn |
| Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥22.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥62.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥55.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥1.11T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥1.11T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥742m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥1.20T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥87.0bn |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥214m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥233m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥732m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥732m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | −¥12.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥2.2bn |
| Foodreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥41.0bn |
| Foodreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥43.6bn |
| Foodreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥865.6bn |
| Foodreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥864.9bn |
| Foodreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥714m |
| Foodreportable segment | segment assets | at 2023-03-31 | ¥823.0bn |
| Foodreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥55.9bn |
| Pharmaceuticalsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥11.3bn |
| Pharmaceuticalsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥9.7bn |
| Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥197.3bn |
| Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥197.3bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥17m |
| Pharmaceuticalsreportable segment | segment assets | at 2023-03-31 | ¥326.1bn |
| Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥21.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥52.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥53.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥1.06T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥1.06T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥732m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥1.15T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥77.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,962
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -28293000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -76997000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -54734000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -43772000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 37110000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 39011000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 64872000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 60939000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant | 102832000000 | JPY |
| Number of employees | Prior4YearInstant | 17571 | |
| Number of employees | Prior3YearInstant | 17832 | |
| Number of employees | Prior2YearInstant | 17336 | |
| Number of employees | Prior1YearInstant | 17290 | |
| Number of employees | CurrentYearInstant | 17270 | |
| Average number of temporary workers | Prior4YearInstant | 9234 | |
| Average number of temporary workers | Prior3YearInstant | 8369 | |
| Average number of temporary workers | Prior2YearInstant | 7864 | |
| Average number of temporary workers | Prior1YearInstant | 7242 | |
| Average number of temporary workers | CurrentYearInstant | 6835 | |
| Operating revenue1 (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 23290000000 | JPY |
| Operating revenue1 (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 25537000000 | JPY |
| Operating revenue1 (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 34547000000 | JPY |
| Operating revenue1 (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 28063000000 | JPY |
| Operating revenue1 (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 30636000000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 21065000000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 22924000000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 31055000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 23924000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 24894000000 | JPY |
| Net income loss (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 21133000000 | JPY |
| Net income loss (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 22354000000 | JPY |
| Net income loss (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 31735000000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 28336000000 | JPY |
| Net income loss (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 32862000000 | JPY |
| Capital stock (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 30000000000 | JPY |
| Capital stock (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 30000000000 | JPY |
| Capital stock (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 30000000000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 30000000000 | JPY |
| Capital stock (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 30000000000 | JPY |
| Total number of issued shares (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 152683000 | |
| Total number of issued shares (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 152683000 | |
| Total number of issued shares (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 148369000 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 148369000 | |
| Total number of issued shares (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 293459000 | |
| Net assets (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 262229000000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 266121000000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 246042000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 238387000000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 244216000000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 378754000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |